DIVOZILIMAB
UNII 13ZEQ1M5ML

Substance Identification & Data

This profile provides standardized clinical and technical data for Divozilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 13ZEQ1M5ML.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2254061-60-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

13ZEQ1M5ML

CAS Registry Number

2254061-60-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DIVOZILIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175772

National Cancer Institute reference terminology for clinical and research data.

INN ID

11336

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Divozilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DIVOZILIMAB

Common Names & Synonyms

DIVOZILIMAB [INN]

DIVOZILIMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL BCD-132 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BCD-132 .KAPPA.-CHAIN, DIMER

External Clinical & Regulatory Resources

Previous UNII13Z9HTH115

Next UNII13ZPK7A4MJ